Hannah Petrenko
Family · Anaheim, CANPI 1457027211
Payments from drug & device makers
Across 171 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$882
- Astellas Pharma US Inc$680
- GSK$296
- Lilly USA, LLC$255
- Novo Nordisk$254
- Otsuka America Pharmaceutical, Inc.$246
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,84597%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 51 | $882 |
| Astellas Pharma US Inc | 20 | $680 |
| GSK | 6 | $296 |
| Lilly USA, LLC | 13 | $255 |
| Novo Nordisk | 13 | $254 |
| Otsuka America Pharmaceutical, Inc. | 11 | $246 |
| Novartis | 10 | $179 |
| Sanofi-aventis U.S. LLC | 4 | $126 |
| Bayer | 5 | $105 |
| Merck | 4 | $99 |
| Boehringer Ingelheim | 4 | $91 |
| AbbVie | 4 | $87 |
| Pfizer | 4 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $83 |
| Insulet Corporation | 2 | $83 |
| Corcept Therapeutics | 2 | $78 |
| VBI Vaccine (delaware) Inc. | 2 | $47 |
| Phadia US Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $41 |
| Pharmaessentia USA Corporation | 1 | $24 |
| Organon | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Abbott | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,945 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SyringeEvolocumab | 18 | $19,880 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,179 |
| Diclofenac Sodium | 43 | $755 |
| Fluticasone Propionate | 89 | $740 |
| Levothyroxine Sodium | 53 | $697 |
| Atorvastatin Calcium | 72 | $637 |
| Rosuvastatin Calcium | 19 | $621 |
| Lisinopril | 39 | $489 |
| Metformin Hcl | 65 | $468 |
| Famotidine | 33 | $458 |
| Amlodipine Besylate | 78 | $385 |
| Metoprolol Succinate | 26 | $384 |
| Gabapentin | 28 | $309 |
| Tamsulosin Hcl | 21 | $270 |
| Lovastatin | 25 | $228 |
Paid to pharmacies, not to this prescriber.
Other family in Anaheim
- Sofia KimAnaheim$32K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.